نتائج البحث - CharlesB Brendler

  • يعرض 1 - 11 نتائج من 11
تنقيح النتائج
  1. 1
    Advanced small cell carcinoma of the bladder successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

    Advanced small cell carcinoma of the bladder successful treatment with combined radical cystoprostatectomy and adjuvant methotrexate, vinblastine, doxorubicin, and cisplatin chemot... حسب Joseph E. Oesterling, Charles B. Brendler, John K. Burgers, Fray F. Marshall, Jonathan I. Epstein

    منشور في 1990
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer

    Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer حسب Rong Na, CarlyA Conran, Haitao Chen, Deke Jiang, Xiaoling Lin, SLilly Zheng, CharlesB Brendler, Jianfeng Xu

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Serum/glucocorticoid‐regulated kinase 1 expression in primary human prostate cancers

    Serum/glucocorticoid‐regulated kinase 1 expression in primary human prostate cancers حسب Russell Z. Szmulewitz, Elizabeth Chung, Hikmat Al‐Ahmadie, Silver Daniel, Masha Kocherginsky, Aria Razmaria, Gregory P. Zagaja, Charles B. Brendler, Walter M. Stadler, Suzanne D. Conzen

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases

    Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone Metastases حسب Yuefeng Yang, Weidong Xu, Thomas Neill, Zebin Hu, Chi-Hsiung Wang, Xianghui Xiao, Stuart R. Stock, Theresa A. Guise, Chae‐Ok Yun, Charles B. Brendler, Renato V. Iozzo, Prem Seth

    منشور في 2015
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer

    The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer حسب Weidong Xu, Thomas Neill, Yang� Yang, Zhigang Hu, E Cleveland, Ying Wu, Ryan Hutten, X. Xiao, Stuart R. Stock, Daniel H. Shevrin, Karen L. Kaul, Charles B. Brendler, Renato V. Iozzo, Prem Seth

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model

    Systemic Delivery of Oncolytic Adenoviruses Targeting Transforming Growth Factor-β Inhibits Established Bone Metastasis in a Prostate Cancer Mouse Model حسب Zebin Hu, Janhavi Gupta, Zhenwei Zhang, Helen Gerseny, Arthur Berg, Yun‐Ju Chen, Zhiling Zhang, Hongyan Du, Charles B. Brendler, Xianghui Xiao, Kenneth J. Pienta, Theresa A. Guise, Chung Lee, Paula H. Stern, Stuart R. Stock, Prem Seth

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker

    Alpha‐methylacyl‐CoA racemase: a multi‐institutional study of a new prostate cancer marker حسب Z. Jiang, Chin‐Lee Wu, Bruce A. Woda, Kenneth A. Iczkowski, P Chu, Maria Tretiakova, Robert H. Young, Lawrence M. Weiss, Robert Blute, Charles B. Brendler, Thomas Krausz, Jiangchun Xu, Kenneth L. Rock, Mahul B. Amin, Ximing J. Yang

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

    Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer حسب H. Ballentine Carter, Brian T. Helfand, Mufaddal Mamawala, Yishuo Wu, Patricia Landis, Hongjie Yu, Kathleen E. Wiley, Rong Na, Zhuqing Shi, Jacqueline Petkewicz, Sameep Shah, Richard J Fantus, Kristian Novakovic, Charles B. Brendler, S. Lilly Zheng, William B. Isaacs, Jianfeng Xu

    منشور في 2018
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    TGF-β Regulates DNA Methyltransferase Expression in Prostate Cancer, Correlates with Aggressive Capabilities, and Predicts Disease Recurrence

    TGF-β Regulates DNA Methyltransferase Expression in Prostate Cancer, Correlates with Aggressive Capabilities, and Predicts Disease Recurrence حسب Qiang Zhang, Lin Chen, Brian T. Helfand, Thomas L. Jang, Vidit Sharma, James M. Kozlowski, Timothy M. Kuzel, Lihua Julie Zhu, Ximing J. Yang, Borko Javonovic, Yinglu Guo, Scott Lonning, Jay Harper, Beverly A. Teicher, Charles B. Brendler, Nengwang Yu, William J. Catàlona, Chung Lee

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial

    Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial حسب Haitao Chen, Xu Liu, Charles B. Brendler, Donna P. Ankerst, Robin J. Leach, Phyllis J. Goodman, M. Scott Lucia, Catherine M. Tangen, Li Wang, Fang‐Chi Hsu, Jielin Sun, A. Karim Kader, William B. Isaacs, Brian T. Helfand, S. Lilly Zheng, Ian M. Thompson, Elizabeth A. Platz, Jianfeng Xu

    منشور في 2016
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

    Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death حسب Rong Na, S. Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M. Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz, Kamalakar Gulukota, Donald L. Helseth, Margo Quinn, Elizabeth Humphries, Kathleen E. Wiley, Sarah D. Isaacs, Yishuo Wu, Xu Liu, Ning Zhang, Chi-Hsiung Wang, Janardan D. Khandekar, Peter J. Hulick, Daniel H. Shevrin, Kathleen A. Cooney, Zhoujun Shen, Alan W. Partin, H. Ballentine Carter, Michael A. Carducci, Mario A. Eisenberger, S. Denmeade, Michael McGuire, Patrick C. Walsh, Brian T. Helfand, Charles B. Brendler, Qiang Ding, Jianfeng Xu, William B. Isaacs

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: